September 2003

Wyeth Wins Bench Trial and Permanent Injunction in Trade Secret Misappropriation Case

North America - United States | North America | United States - Minnesota

Wyeth, a global pharmaceutical company acquired by Pfizer in 2009, won a bench trial and permanent injunction in a trade secret misappropriation case in the District of Minnesota involving Wyeth’s trade secret chemical process for manufacturing Premarin®, a drug with sales in excess of $1 billion. The district court entered a permanent injunction preventing the competitor from entering the market with the first generic version of the drug. The decision was later upheld on appeal.

The Faegre Baker Daniels website uses cookies to make your browsing experience as useful as possible. In order to have the full site experience, keep cookies enabled on your web browser. By browsing our site with cookies enabled, you are agreeing to their use. Review Faegre Baker Daniels' cookies information for more details.